| Literature DB >> 29566051 |
Seung Eun Lee1, Kyungdo Han2, Yu Mi Kang1, Seon-Ok Kim3, Yun Kyung Cho1, Kyung Soo Ko4, Joong-Yeol Park1, Ki-Up Lee1, Eun Hee Koh1.
Abstract
BACKGROUND: The prevalence of metabolic syndrome has markedly increased worldwide. However, studies in the United States show that it has remained stable or slightly declined in recent years. Whether this applies to other countries is presently unclear.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29566051 PMCID: PMC5864027 DOI: 10.1371/journal.pone.0194490
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of Korean adults who participated in regular health check-ups, between 2009 and 2013.
| Year | |||||||||
| 2009 | 2010 | 2011 | 2012 | 2013 | |||||
| Number of participants | 9,069,127 | 10,135,257 | 10,399,685 | 10,974,490 | 10,583,081 | ||||
| Age (years) | 50.1 (12.5) | 50.1 (12.5) | 50.2 (12.6) | 50.5 (12.5) | 50.8 (12.7) | <0.01 | |||
| Men (%) | 55.14 | 55.18 | 54.99 | 54.61 | 54.53 | <0.01 | |||
| BMI (kg/m2) | 23.9 (3.1) | 23.9 (3.2) | 23.9 (3.2) | 23.9 (3.2) | 23.9 (3.3) | <0.01 | |||
| WC (cm) | 81.0 (8.8) | 80.8 (8.9) | 80.9 (8.9) | 80.8 (9) | 81 (9.1) | <0.01 | |||
| Physically active subjects (%) | 22.96 | 23.59 | 23.78 | 24.59 | 25.41 | <0.01 | |||
| Current smoker, n(%) | 25.18 | 24.47 | 24.75 | 24.02 | 24.11 | <0.01 | |||
| Heavy drinker, n(%) | 7.68 | 7.58 | 7.49 | 7.27 | 7.22 | <0.01 | |||
BMI, body mass index; WC, waist circumference.
aAge, BMI, and WC were expressed as mean (SD).
Fig 1Trends in metabolic syndrome in Korea.
The trends in metabolic syndrome prevalence among Korean adults, who participated in regular health check-ups between 2009 and 2013. A: Overall population (P for trend <0.01). B: Comparison between men and women (P <0.001). C: Age-specific trends of metabolic syndrome and ORs per year between 2009 and 2013. *Age-stratified logistic regression was used for the calculation of OR per year. OR = Odds ratio.
Fig 2The trends of each component of metabolic syndrome.
The trends of each component of metabolic syndrome in individuals stratified by gender. P for trends were all significant (P <0.01). BP = blood pressure, HDL = high-density lipoprotein.
Proportion of subjects meeting the criteria for components of metabolic syndrome stratified by gender.
| Year | Percent change over the 4 years | |||||
| 2009 | 2010 | 2011 | 2012 | 2013 | ||
| WC | 29.39 | 28.95 | 29.26 | 28.95 | 29.63 | 0.24 |
| Men (>90cm) (%) | 22.48 | 22.58 | 23.05 | 23.05 | 23.80 | 1.32 |
| Women (>80cm) (%) | 35.82 | 34.88 | 35.05 | 34.44 | 35.06 | -0.76 |
| TG (≥150mg/dL or medication use) | 35.46 | 35.66 | 36.11 | 36.14 | 37.00 | 1.54 |
| Men (%) | 43.65 | 43.77 | 44.44 | 44.33 | 44.99 | 1.34 |
| Women (%) | 27.84 | 28.11 | 28.36 | 28.52 | 29.55 | 1.71 |
| HDL cholesterol | 29.92 | 29.80 | 30.18 | 30.71 | 31.73 | 1.80 |
| Men (<40mg/dL or medication use) (%) | 22.61 | 23.01 | 23.77 | 24.77 | 26.03 | 3.42 |
| Women (<50mg/dL or medication use) (%) | 36.73 | 36.12 | 36.15 | 36.24 | 37.04 | 0.31 |
| Fasting glucose (≥100mg/dL or medication use) | 32.88 | 32.53 | 32.65 | 32.86 | 34.10 | 1.22 |
| Men (%) | 38.42 | 38.38 | 38.59 | 38.97 | 40.15 | 1.73 |
| Women (%) | 27.73 | 27.09 | 27.13 | 27.18 | 28.47 | 0.74 |
| BP (≥130/85mmHg or medication use) | 45.29 | 44.92 | 44.84 | 44.44 | 43.94 | -1.35 |
| Men (%) | 51.83 | 51.94 | 51.87 | 51.68 | 51.03 | -0.80 |
| Women (%) | 39.20 | 38.40 | 38.30 | 37.70 | 37.34 | -1.86 |
BP, blood pressure; HDL, high-density lipoprotein; TG, triglyceride; WC, waist circumference.
aGeneral linear model was used for significance of trend from 2009 to 2013. P for trend < 0.01 for all comparison.
Fig 3Forest plots of the ORs and CIs of components of metabolic syndrome (2013 versus 2009).
BP = blood pressure, CI = confidence interval, HDL = high-density lipoprotein, OR = odds ratio.
Prevalence of metabolic syndrome* and its components in individuals with or without IFG.
| Year | Percent change over the 4 years | |||||
| 2009 | 2010 | 2011 | 2012 | 2013 | ||
| Metabolic syndrome | ||||||
| Normal fasting glucose (%) | 36.54 | 36.03 | 36.24 | 36.02 | 36.48 | -0.06 |
| IFG (%) | 52.46 | 52.80 | 53.63 | 53.71 | 54.50 | 2.03 |
| Abdominal obesity | ||||||
| Normal fasting glucose (%) | 25.76 | 25.24 | 25.46 | 25.06 | 25.47 | -0.29 |
| IFG (%) | 37.07 | 37.00 | 37.68 | 37.58 | 38.47 | 1.40 |
| TG (≥150 mg/dL or medication use) | ||||||
| Normal fasting glucose (%) | 30.81 | 30.82 | 31.11 | 31.04 | 31.63 | 0.82 |
| IFG (%) | 44.52 | 45.27 | 46.18 | 46.28 | 47.20 | 2.68 |
| HDL-cholesterol | ||||||
| Normal fasting glucose (%) | 27.27 | 26.90 | 27.08 | 27.50 | 28.25 | 0.98 |
| IFG (%) | 34.97 | 35.46 | 36.27 | 37.00 | 38.16 | 3.19 |
| BP (≥130/85 mmHg or medication use) | ||||||
| Normal fasting glucose (%) | 40.95 | 40.50 | 40.37 | 39.84 | 39.11 | -1.85 |
| IFG (%) | 54.04 | 54.08 | 54.11 | 53.95 | 53.40 | -0.64 |
BP, blood pressure; IFG, impaired fasting glucose; TG, triglyceride.
aMetabolic syndrome was defined as having two or more of the four components.
bGeneral linear model was used for significance of trend from 2009 to 2013. p for trend <0.01 for all comparison.